vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and TRIMAS CORP (TRS). Click either name above to swap in a different company.
TRIMAS CORP is the larger business by last-quarter revenue ($256.5M vs $158.6M, roughly 1.6× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 31.9%, a 39.3% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 3.8%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $36.8M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.
STOK vs TRS — Head-to-Head
Income Statement — Q1 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $256.5M |
| Net Profit | $112.9M | $81.7M |
| Gross Margin | — | 12.8% |
| Operating Margin | 70.2% | 5.7% |
| Net Margin | 71.2% | 31.9% |
| Revenue YoY | 3661.1% | 3.8% |
| Net Profit YoY | 528.0% | 236.9% |
| EPS (diluted) | $1.90 | $2.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.5M | ||
| Q4 25 | — | $-140.0M | ||
| Q3 25 | — | $269.3M | ||
| Q2 25 | — | $274.8M | ||
| Q1 25 | $158.6M | $241.7M | ||
| Q4 24 | $22.6M | $-66.2M | ||
| Q3 24 | — | $229.4M | ||
| Q2 24 | — | $240.5M |
| Q1 26 | — | $81.7M | ||
| Q4 25 | — | $81.7M | ||
| Q3 25 | — | $9.3M | ||
| Q2 25 | — | $16.7M | ||
| Q1 25 | $112.9M | $12.4M | ||
| Q4 24 | $-10.5M | $5.6M | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $10.9M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 12.8% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.4% | ||
| Q2 24 | — | 14.4% |
| Q1 26 | — | 5.7% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 9.9% | ||
| Q1 25 | 70.2% | 9.0% | ||
| Q4 24 | -60.4% | — | ||
| Q3 24 | — | 3.6% | ||
| Q2 24 | — | 7.4% |
| Q1 26 | — | 31.9% | ||
| Q4 25 | — | -58.4% | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | 71.2% | 5.1% | ||
| Q4 24 | -46.4% | -8.5% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | $2.03 | ||
| Q4 25 | — | $2.01 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | $1.90 | $0.30 | ||
| Q4 24 | $-0.15 | $0.14 | ||
| Q3 24 | — | $0.06 | ||
| Q2 24 | — | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $30.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.1M | $705.6M |
| Total Assets | $406.9M | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $30.0M | ||
| Q4 25 | — | $30.0M | ||
| Q3 25 | — | $33.6M | ||
| Q2 25 | — | $30.3M | ||
| Q1 25 | $274.8M | $32.7M | ||
| Q4 24 | $128.0M | $23.1M | ||
| Q3 24 | — | $26.9M | ||
| Q2 24 | — | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $469.2M | ||
| Q3 25 | — | $407.1M | ||
| Q2 25 | — | $424.5M | ||
| Q1 25 | — | $434.2M | ||
| Q4 24 | — | $398.1M | ||
| Q3 24 | — | $409.9M | ||
| Q2 24 | — | $427.4M |
| Q1 26 | — | $705.6M | ||
| Q4 25 | — | $705.6M | ||
| Q3 25 | — | $725.0M | ||
| Q2 25 | — | $715.3M | ||
| Q1 25 | $350.1M | $686.6M | ||
| Q4 24 | $229.0M | $667.3M | ||
| Q3 24 | — | $682.8M | ||
| Q2 24 | — | $675.9M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | $406.9M | $1.4B | ||
| Q4 24 | $271.6M | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $117.5M |
| Free Cash FlowOCF − Capex | $131.7M | $36.8M |
| FCF MarginFCF / Revenue | 83.0% | 14.4% |
| Capex IntensityCapex / Revenue | 0.1% | 18.9% |
| Cash ConversionOCF / Net Profit | 1.17× | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | — | $109.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $117.5M | ||
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | — | $30.3M | ||
| Q1 25 | $131.8M | $9.2M | ||
| Q4 24 | $-23.2M | $27.1M | ||
| Q3 24 | — | $22.0M | ||
| Q2 24 | — | $18.4M |
| Q1 26 | — | $36.8M | ||
| Q4 25 | — | $36.8M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | — | $13.2M | ||
| Q1 25 | $131.7M | $-3.8M | ||
| Q4 24 | $-23.2M | $12.1M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | — | $7.5M |
| Q1 26 | — | 14.4% | ||
| Q4 25 | — | -26.3% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | 83.0% | -1.6% | ||
| Q4 24 | -102.7% | -18.3% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | — | 3.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | — | -3.4% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | 0.1% | 5.4% | ||
| Q4 24 | 0.2% | -22.6% | ||
| Q3 24 | — | 5.2% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | 1.44× | ||
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 3.92× | ||
| Q2 25 | — | 1.81× | ||
| Q1 25 | 1.17× | 0.74× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | — | 8.71× | ||
| Q2 24 | — | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
